Sanofi: all 2,424 studies
Page 5 of 25. Open to participants first (105), then studies with results posted, then the rest; newest registration first within each.
- Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients With Relapsing Forms of Multiple SclerosisCompletedNCT02201108Phase 3Results posted
- Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy AdolescentsCompletedNCT02199691Phase 2Results posted
- Study of the Combination of KD019 and Trastuzumab in Subjects With HER2-Positive Metastatic Breast CancerTerminatedNCT02154529Phase 1/2Results posted
- Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE)CompletedNCT02134028Phase 3Results posted
- To Evaluate the Immunogenicity and Safety of Sarilumab Administered as Monotherapy in Patients With Rheumatoid Arthritis (RA)CompletedNCT02121210Phase 3Results posted
- Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® VaccineCompletedNCT02117934Phase 3Results posted
- Efficacy and Safety Evaluation of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia or High Cardiovascular Risk Patients With Hypercholesterolemia on Lipid Modifying Therapy (ODYSSEY JAPAN)CompletedNCT02107898Phase 3Results posted
- A Safety and Tolerability Study of Belumosudil (KD025) Treatment in Subjects With Moderately Severe Psoriasis VulgarisCompletedNCT02106195Phase 2Results posted
- Study of SP306 Given Intramuscularly Compared to DT Given Subcutaneously in Japanese Adolescents 11 - 12 Years OldCompletedNCT02089347Phase 3Results posted
- Pharmacokinetics of rFVIIIFc at Two Vial StrengthsCompletedNCT02083965Phase 1Results posted
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 DiabetesCompletedNCT02058160Phase 3Results posted
- Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DMCompletedNCT02058147Phase 3Results posted
- To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid ArthritisCompletedNCT02057250Phase 3Results posted
- Avalglucosidase Alfa Extension StudyCompletedNCT02032524Phase 2Results posted
- Phase III Study To Evaluate Alirocumab in Patients With Hypercholesterolemia Not Treated With a Statin (ODYSSEY CHOICE II)CompletedNCT02023879Phase 3Results posted
- Study of IMOVAX POLIO® Subcutaneous as a Booster Vaccine in Pre-school Age Children in JapanCompletedNCT02005536Phase 4Results posted
- A Long-Term Study of Olipudase Alfa in Patients With Acid Sphingomyelinase DeficiencyCompletedNCT02004704Phase 2Results posted
- Efficacy, Safety, Pharmacodynamic, and Pharmacokinetics Study of Olipudase Alfa in Patients With Acid Sphingomyelinase DeficiencyCompletedNCT02004691Phase 2/3Results posted
- Long-Term Study of Hospitalized Dengue & Safety in Thai Children Included in a Tetravalent Dengue Vaccine Efficacy StudyCompletedNCT01983553Results posted
- Post-licensure Safety Study of IMOJEV® in ThailandCompletedNCT01981967Phase 4Results posted
- Study of a Quadrivalent Influenza Vaccine Administered Via the Intramuscular Route in Children and Adolescents in TaiwanCompletedNCT01967784Phase 3Results posted
- Study of Aflibercept as Maintenance Therapy Following Induction With Aflibercept in Combination With XELOX, as First-Line Treatment for Metastatic Colorectal Cancer PatientTerminatedNCT01955629Phase 1/2Results posted
- Open Label Study of Long Term Safety Evaluation of AlirocumabCompletedNCT01954394Phase 3Results posted
- Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine in Indian Infants Previously Given a Dose of Hepatitis B Vaccine at BirthCompletedNCT01948193Phase 3Results posted
- Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose Influenza Virus Vaccines in AdultsCompletedNCT01946438Phase 4Results posted
- Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent Influenza Virus VaccineCompletedNCT01946425Phase 4Results posted
- Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue VaccineCompletedNCT01943825Phase 2Results posted
- Study of the Tdap Combined Vaccine (ADACEL™) as a Booster Dose in Healthy Adults and Children in ChinaCompletedNCT01933776Phase 1Results posted
- An Evaluation of Dupilumab in Patients With Nasal Polyposis And Chronic Symptoms Of SinusitisCompletedNCT01920893Phase 2Results posted
- Study of a Booster Dose of IMOJEV® One Year After Primary Immunization in Healthy Children in South KoreaCompletedNCT01900444Phase 3Results posted
- Phase II Study to Analyze Sarilumab in Non-Infectious UveitisCompletedNCT01900431Phase 2Results posted
- Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) PatientsCompletedNCT01895335Phase 4Results posted
- Immunogenicity and Safety of Menactra® Vaccine in Subjects Aged 9 to 23 Months in India and in the Russian FederationCompletedNCT01890759Phase 3Results posted
- Study of a Candidate Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile InfectionTerminatedNCT01887912Phase 3Results posted
- A Study of Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in JapanCompletedNCT01882868Phase 2Results posted
- Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid CancerCompletedNCT01876784Phase 3Results posted
- An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled AsthmaCompletedNCT01854047Phase 2Results posted
- Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) in Patients With Primary Hypercholesterolemia on Stable Atorvastatin Therapy in JapanCompletedNCT01812707Phase 2Results posted
- Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic PatientsCompletedNCT01798706Phase 3Results posted
- To Evaluate The Safety of SAR153191 (REGN88) and Tocilizumab Added to Other RA Drugs in Patients With RA Who Are Not Responding to or Intolerant of Anti-TNF Therapy (SARIL-RA-ASCERTAIN)CompletedNCT01768572Phase 3Results posted
- Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic PatientsCompletedNCT01768559Phase 3Results posted
- An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus MethotrexateTerminatedNCT01764997Phase 3Results posted
- Safety and Efficacy of Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Central Nervous System TumorsCompletedNCT01751308Phase 1/2Results posted
- Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and OlderCompletedNCT01732627Phase 2Results posted
- Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)CompletedNCT01718353Phase 2Results posted
- Study of Intradermal Quadrivalent Influenza Vaccine in Adults Aged 18 Through 64 YearsCompletedNCT01712984Phase 3Results posted
- To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)CompletedNCT01709578Phase 3Results posted
- Study of Fluzone® Influenza Virus Vaccines 2012-2013 Formulation Among Adults.CompletedNCT01691339Phase 4Results posted
- Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Influenza Virus Vaccine (2012-2013 Formulation)CompletedNCT01691326Phase 4Results posted
- Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in AdolescentsCompletedNCT01689324Phase 1/2Results posted
- Post-licensure Safety Surveillance Study of Menactra Vaccine When Administered As a 2-dose Schedule to ChildrenCompletedNCT01689155Results posted
- Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes MellitusCompletedNCT01683266Phase 3Results posted
- Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic TherapyCompletedNCT01676220Phase 3Results posted
- Colorectal Cancer MetastaticCompletedNCT01670721Phase 3Results posted
- ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With AlirocumabCompletedNCT01663402Phase 3Results posted
- A Study of Aflibercept Versus Placebo With FOLFIRI in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin ChemotherapyCompletedNCT01661270Phase 3Results posted
- Evaluate the Safety and Tolerability of Vandetanib in Japanese Patients With Medullary Thyroid CarcinomaCompletedNCT01661179Phase 1/2Results posted
- Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of AgeCompletedNCT01659996Phase 4Results posted
- Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus on Basal Plus Mealtime InsulinCompletedNCT01658579Phase 2Results posted
- A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase BetaCompletedNCT01650779Phase 4Results posted
- Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe in Patients With HypercholesterolemiaCompletedNCT01644474Phase 3Results posted
- Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe on Top of Statin in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY COMBO II)CompletedNCT01644188Phase 3Results posted
- Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia (ODYSSEY COMBO I)CompletedNCT01644175Phase 3Results posted
- Safety and Immunogenicity Study for Use of Menactra® Versus Adacel® in Subjects 11 to 55 Years of Age in South KoreaCompletedNCT01642589Phase 3Results posted
- Immunogenicity of Adacel® and BOOSTRIX® Vaccines in AdolescentsCompletedNCT01629589Phase 4Results posted
- Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying TherapyCompletedNCT01623115Phase 3Results posted
- A Study of the Safety and Effectiveness of Synvisc-One® (Hylan G-F 20) in Patients With Primary Osteoarthritis of the HipCompletedNCT01618708Not applicableResults posted
- Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia (ODYSSEY HIGH FH)CompletedNCT01617655Phase 3Results posted
- Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese SubjectsCompletedNCT01608815Phase 3Results posted
- A Noninferiority Study of Alglucosidase Alfa Manufactured at the 160 L and 4000 L Scales in Treatment Naïve Patients With Infantile-Onset Pompe DiseaseTerminatedNCT01597596Phase 4Results posted
- Pharmacodynamic Effects of Lixisenatide Compared to Liraglutide in Patients With Type 2 Diabetes Not Adequately Controlled With Insulin Glargine With or Without MetforminCompletedNCT01596504Phase 2Results posted
- Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination RegimenCompletedNCT01587040Phase 1/2Results posted
- A Study of the Efficacy and Safety of Synvisc® in Chinese Subjects With Symptomatic Osteoarthritis of the Knee(s)CompletedNCT01586338Phase 4Results posted
- An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Participants With Chronic Kidney DiseaseCompletedNCT01574326Phase 2Results posted
- Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based RegimenCompletedNCT01571284Phase 3Results posted
- A Safety, Pharmacokinetic & Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT01559363Phase 1/2Results posted
- Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in IndiaCompletedNCT01550289Phase 2Results posted
- A Study to Evaluate the Efficacy and Safety of Alglucosidase Alfa Produced at the 4000 L Scale for Pompe DiseaseTerminatedNCT01526785Phase 4Results posted
- Study of a Single Dose of Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (SP284) in Japanese SubjectsCompletedNCT01519713Phase 3Results posted
- Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on MetforminCompletedNCT01517412Phase 3Results posted
- Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric CancerCompletedNCT01515748Phase 3Results posted
- Cabazitaxel and Abiraterone Acetate in Patients With Metastatic Castrate-Resistant Prostate CancerCompletedNCT01511536Phase 1/2Results posted
- Long-term Safety and Tolerability of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY Long Term)CompletedNCT01507831Phase 3Results posted
- Study of SAR421869 in Participants With Retinitis Pigmentosa Associated With Usher Syndrome Type 1BTerminatedNCT01505062Phase 1/2Results posted
- Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung CancerCompletedNCT01500720Phase 2Results posted
- Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic TherapyCompletedNCT01499095Phase 3Results posted
- Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime InsulinCompletedNCT01499082Phase 3Results posted
- To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid CancerCompletedNCT01496313Phase 4Results posted
- Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever VaccineCompletedNCT01488890Phase 2Results posted
- Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic PatientsCompletedNCT01476475Phase 2Results posted
- Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Recombinant Coagulation Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Pediatric Subjects With Hemophilia ACompletedNCT01458106Phase 3Results posted
- Long-Term Safety and Efficacy of rFVIIIFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia ACompletedNCT01454739Phase 3Results posted
- Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy InfantsCompletedNCT01444781Phase 3Results posted
- Study of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra VaccineCompletedNCT01442675Phase 2Results posted
- Study of Recombinant Coagulation Factor IX Fc Fusion Protein, BIIB029, in Previously Treated Pediatric Participants With Hemophilia BCompletedNCT01440946Phase 3Results posted
- Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous DoseCompletedNCT01439165Phase 4Results posted
- Regulatory Post-Marketing Surveillance Study for TETRAXIM™CompletedNCT01437423Phase 4Results posted
- Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy ToddlersCompletedNCT01436396Phase 3Results posted
- Study of Fluzone® Influenza Virus Vaccine 2011-2012 Formulation (Intramuscular Route) Among AdultsCompletedNCT01430819Phase 4Results posted
- Study of Sanofi Pasteur and Lanzhou Institute's Meningococcal (Group A and C) Polysaccharide Vaccine in ChildrenCompletedNCT01430611Phase 4Results posted